MedPath

Viiral Nordic AB

🇸🇪Sweden
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

1

Active:0
Completed:1

Trial Phases

1 Phases

Not Applicable:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Not Applicable
1 (100.0%)

A Post-Market Clinical Follow-up Investigation to Verify Performance and Safety of Viiral®Nasal Spray in Subjects With Dry Nose Symptoms

Not Applicable
Completed
Conditions
Rhinitis Sicca
First Posted Date
2022-03-03
Last Posted Date
2022-10-13
Lead Sponsor
Viiral Nordic AB
Target Recruit Count
84
Registration Number
NCT05264350
Locations
🇸🇪

Universitetssjukhuset, Avdelning för kliniska prövningar, Örebro, Region Örebro, Sweden

🇸🇪

Cordinator Medical Service AB, Linköping, Region Östergötland, Sweden

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.